BSE - Delayed Quote INR
Medi-Caps Limited (MEDICAPQ.BO)
43.50
-0.79
(-1.78%)
At close: May 23 at 3:27:36 PM GMT+5:30
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Total Revenue
258,578
265,636
485,775
683,110
574,157
Cost of Revenue
121,431
110,536
251,088
334,542
320,761
Gross Profit
137,147
155,100
234,687
348,568
253,396
Operating Expense
179,812
177,855
206,537
266,054
148,880
Operating Income
-42,665
-22,755
28,150
82,514
104,516
Net Non Operating Interest Income Expense
4,884
4,884
4,890
4,217
2,375
Pretax Income
-28,781
-12,460
49,208
100,577
112,398
Tax Provision
4,891
9,947
30,544
144
-51
Net Income Common Stockholders
-33,673
-22,408
17,557
100,805
111,290
Diluted NI Available to Com Stockholders
-33,673
-22,408
17,557
100,805
111,290
Basic EPS
-2.71
-1.80
1.41
8.08
8.93
Diluted EPS
-2.71
-1.80
1.41
8.08
8.93
Basic Average Shares
12,424.32
12,469.96
12,469.96
12,469.96
12,469.96
Diluted Average Shares
12,424.32
12,469.96
12,469.96
12,469.96
12,469.96
Rent Expense Supplemental
--
454
345
316
221
Total Expenses
301,243
288,391
457,625
600,596
469,641
Net Income from Continuing & Discontinued Operation
-33,673
-22,408
17,557
100,805
111,290
Normalized Income
-35,017.70
-23,752.70
13,675.10
95,693.80
112,680
Interest Income
--
5,250
6,169
5,299
3,402
Interest Expense
0
0
16
97
0
Net Interest Income
4,884
4,884
4,890
4,217
2,375
EBIT
-28,781
-12,460
49,224
100,674
112,398
EBITDA
-12,728
4,405
67,334
119,701
130,920
Reconciled Cost of Revenue
121,431
110,536
251,088
334,542
320,761
Reconciled Depreciation
16,053
16,865
18,110
19,027
18,522
Net Income from Continuing Operation Net Minority Interest
-33,673
-22,408
18,664
100,433
112,449
Total Unusual Items Excluding Goodwill
1,921
1,921
7,127
4,746
-330
Total Unusual Items
1,921
1,921
7,127
4,746
-330
Normalized EBITDA
-14,649
2,484
60,207
114,955
131,250
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
576.30
576.30
2,138.10
6.80
-99
3/31/2021 - 12/30/2024
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade